Huansu Xu

2010-2011 Physics Hong Kong University of Science and Technology, Clear Water Bay, New Territories, Hong Kong 
"Huansu Xu"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yuan X, Xi H, Le Y, et al. (2021) Online survey on healthcare skin reactions for wearing medical-grade protective equipment against COVID-19 in Hubei Province, China. Plos One. 16: e0250869
Li S, Zheng Y, Sun W, et al. (2021) Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging. European Radiology
Hu HM, Long WG, Wang X, et al. (2021) Recurrent infantile digital fibromatosis with HPV infection: a case report. Ame Case Reports. 5: 20
Xu HM, Huang HL, Xu J, et al. (2021) Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation. Frontiers in Microbiology. 12: 658292
Liu W, Zheng Y, Zhang F, et al. (2021) A Preliminary Investigation on Plasma Cell Adhesion Molecules Levels by Protein Microarray Technology in Major Depressive Disorder. Frontiers in Psychiatry. 12: 627469
Xue X, Jiao F, Xu H, et al. (2021) The role of RNA-binding protein, microRNA and alternative splicing in seed germination: a field need to be discovered. Bmc Plant Biology. 21: 194
Dai Y, Hao P, Sun Z, et al. (2021) Liver knockout YAP gene improved insulin resistance induced hepatic fibrosis. The Journal of Endocrinology
Hu X, Wu C, Lou J, et al. (2021) Potential role of microRNAs in the regulation of pyroptosis (Review). Molecular Medicine Reports. 23
Gao Y, Wu Y, Zhang N, et al. (2021) IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87‑MG cells. Molecular Medicine Reports. 23
Wu Z, Xu H, Zhu S, et al. (2021) Gait Analysis of Old Individuals with Mild Parkinsonian Signs and Those Individuals' Gait Performance Benefits Little from Levodopa. Risk Management and Healthcare Policy. 14: 1109-1118
See more...